Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites.
Alberto FerrareseValerie TikhonoffEdoardo CasigliaPaolo AngeliSilvano FasolatoDiego FaggianAlberto ZanettoGiacomo GermaniFrancesco Paolo RussoPatrizia BurraMarco SenzoloPublished in: Gastroenterology research and practice (2018)
The negative inotropic effect of NSBB was counterbalanced by a smaller decrease of vascular resistances after LVP, probably due to splanchnic β2-blockade. This pilot study showed that NSBB introduction may be void of detrimental hemodynamic effects after LVP in cirrhotics with refractory ascites.
Keyphrases